Safety and Immunogenicity Study of DNA.HTI, MVA.HTI and ChAdOx1.HTI in HIV-1-positive Patients (AELIX-002)
Clinical trial NCT03204617 · COMPLETED
Trial details
- NCT number
- NCT03204617
- Sponsor
- Aelix Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2020-07-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.